PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil
Abstract
Authors
V. Nasciben M.J.D.O. Figueiredo F.C.D.C. Darrieux L.S.P. Piegas S.C.O. Martins